Concomitant use with calcium containing solutions have caused fatal calcium-ceftriaxone precipitates in lungs and kidneys of neonatal humans.
Concomitant use with calcium containing solutions have caused fatal calcium-ceftriaxone precipitates in lungs and kidneys of neonatal humans.
Calcium acetate is not recommended for use in human patients that are on digoxin therapy, as hypercalcemia may cause serious arrhythmias
Potentially could increase risk for cardiotoxicity associated with doxorubicin
Likely to significantly decrease oral bioavailability of alendronate
Possible potentiation of bradycardia, AV block or sinus arrest
Concurrent use of beta-blockers with calcium channel blockers (or other negative inotropics) should be done with caution, particularly in patients ...
Itraconazole may increase levels
Ketoconazole may increase levels
Concurrent use of beta-blockers with calcium channel blockers (or other negative inotropics) should be done with caution, particularly in patients ...
May increase midazolam levels
Pamidronate must be used carefully (with monitoring) when used in conjunction with other drugs that can affect calcium
Potential to increase hypotensive effects; may have additive effects on AV conduction or ventricular function; use with caution, particularly in pa...
May increase bradycardia and hypotension
May increase midazolam levels
Use with calcitriol may induce hypercalcemia
Intravenous calcium may antagonize the effects of calcium-channel blocking agents
Rare reports of cardiovascular collapse in humans; concomitant use with dantrolene during malignant hyperthermia crises not recommended
Can have additive negative effects on AV conduction
Use with vitamin D analogs may induce hypercalcemia